Women's experiences, preferences and perceptions regarding vaginal products: Results from a cross-sectional web-based survey in Portugal

REFERENCES

• Alexander NJ, Baker E, Kaptein M, et al. Why consider vaginal drug administration? Fertil Steril 2004;82:1–12.
   PubMed Web of Science ®Google Scholar
• das Neves J, Palmeira-de-Oliveira R, Palmeira-de-Oliveira A, et al CVaginal mucosa and drug delivery. In Khutoryanskiy VV, ed. Mucoadhesive materials and drug delivery systems. Chichester,UK: Wiley 2014: 99–132.
   Google Scholar
• Dosage forms monographs. Vaginal preparations. In European pharmacopeia 8.0. Strasbourg: EDQM 2014: 812–14.
   Google Scholar
• das Neves J, Amaral MH, Bahia MF. Vaginal drug delivery. In Cox Gad S, ed. Pharmaceutical manufacturing handbook: Production and processes. Hoboken, NJ: Wiley 2008: 809–79.
   Google Scholar
• Machado RM, Palmeira-de-Oliveira A, Martinez-De-Oliveira J, et al. Vaginal films for drug delivery. J Pharm Sci 2013;102:2069–81.
   PubMed Web of Science ®Google Scholar
• Wysocki S, Kingsberg S, Krychman M. Management of vaginal atrophy: Implications from the REVIVE survey. Clin Med Insights Reprod Health 2014;8:23–30.
   PubMedGoogle Scholar
• Nappi RE, Kokot-Kierepa M. Vaginal Health: Insights, Views & Attitudes (VIVA) — results from an international survey. Climacteric 2012;15:36–44.
   PubMed Web of Science ®Google Scholar
• Mårdh P-A, Rodrigues AG, Genç M, et al. Facts and myths on recurrent vulvovaginal candidosis – a review on epidemiology, clinical manifestations, diagnosis, pathogenesis and therapy. Int J STD AIDS 2002;13:522–39.
   PubMed Web of Science ®Google Scholar
• Koumans EH, Sternberg M, Bruce C, et al. The prevalence of bacterial vaginosis in the United States, 2001–2004; Associations with symptoms, sexual behaviors, and reproductive health. Sex Transm Dis 2007;34:864–9.
   PubMed Web of Science ®Google Scholar
• Nappi RE, Liekens G, Brandenburg U. Attitudes, perceptions and knowledge about the vagina: The International Vagina Dialogue Survey. Contraception 2006;73:493–500.
   PubMed Web of Science ®Google Scholar
• Sobel JD. Factors involved in patient choice of oral or vaginal treatment for vulvovaginal candidiasis. Patient Prefer Adherence 2014;8:31–4.
   Web of Science ®Google Scholar
• Elias C, Coggins C. Acceptability research on female- controlled barrier methods to prevent heterosexual transmission of HIV: Where have we been? Where are we going? J Women's Health Gend Based Med 2001;10: 163–73.
   PubMedGoogle Scholar
• Hardy E, de Padua KS, Osis MJ, et al. Women's preferences for vaginal antimicrobial contraceptives. IV. Attributes of a formulation that would protect from STD/AIDS. Contraception 1998;58:251–5.
   PubMed Web of Science ®Google Scholar
• Rice VM, Maimbolwa MC, Nkandu EM, et al. Cultural differences in acceptability of a vaginal microbicide: A comparison between potential users from Nashville, Tennessee, USA, and Kafue and Mumbwa, Zambia. HIV AIDS (Auckl) 2012;4:73–80.
   PubMedGoogle Scholar
• Van den Berg JJ, Rosen RK, Bregman DE, et al.‘Set it and forget it’: Women's perceptions and opinions of long-acting topical vaginal gels. AIDS Behav 2014; 18:862–70.
   PubMed Web of Science ®Google Scholar
• Hammett TM, Mason TH, Joanis CL, et al. Acceptability of formulations and application methods for vaginal microbicides among drug-involved women: Results of product trials in three cities. Sex Transm Dis 2000;27:119–26.
   PubMed Web of Science ®Google Scholar
• Coggins C, Elias CJ, Atisook R, et al. Women's preferences regarding the formulation of over-the-counter vaginal spermicides. AIDS 1998;12:1389–91.
   PubMed Web of Science ®Google Scholar
• Burke AE, Barnhart K, Jensen JT, et al. Contraceptive efficacy, acceptability, and safety of C31G and nonoxynol-9 spermicidal gels: A randomized controlled trial. Obstet Gynecol 2010;116:1265–73.
   PubMed Web of Science ®Google Scholar
• Bentley ME, Fullem AM, Tolley EE, et al. Acceptability of a microbicide among women and their partners in a 4- country phase I trial. Am J Public Health 2004;94:1159–64.
   PubMed Web of Science ®Google Scholar
• Marrazzo JM, Cook RL, Wiesenfeld HC, et al. Women's satisfaction with an intravaginal Lactobacillus capsule for the treatment of bacterial vaginosis. J Women's Health (Larchmt) 2006;15:1053–60.
   PubMed Web of Science ®Google Scholar
• Novak A, de la Loge C, Abetz L, et al. The combined contraceptive vaginal ring, NuvaRing: An international study of user acceptability. Contraception 2003;67:187–94.
   PubMed Web of Science ®Google Scholar
• Hardy E, de Padua KS, Jimenez AL, et al. Women's preferences for vaginal antimicrobial contraceptives. II. Preferred characteristics according to women's age and socioeconomic status. Contraception 1998;58: 239–44.
   PubMed Web of Science ®Google Scholar
• Joglekar A, Rhodes CT, Danish M. Preferences of women for use of intravaginal medications. Drug Dev Ind Pharm 1991;17:2103–13.
   Web of Science ®Google Scholar
• Hardy E, de Padua KS, Jimenez AL, et al. Women's preferences for vaginal antimicrobial contraceptives. I. Methodology. Contraception 1998;58:233–8.
   PubMed Web of Science ®Google Scholar
• Palmeira-de-Oliveira R, Duarte P, Palmeira-de- Oliveira A, et al. What do Portuguese women prefer regarding vaginal products? Results from a cross-sectional web-based survey. 2014; (submitted for publication)
   Google Scholar
• das Neves J, Bahia MF. Gels as vaginal drug delivery systems. Int J Pharm 2006;318:1–14.
   PubMed Web of Science ®Google Scholar
• Donders GGG, Zodzika J, Rezeberga D. Treatment of bacterial vaginosis: What we have and what we miss. Expert Opin Pharmacother 2014;15:645–57.
   PubMed Web of Science ®Google Scholar
• Leiblum SR, Hayes RD, Wanser RA, et al. Vaginal dryness: A comparison of prevalence and interventions in 11 countries. J Sex Med 2009;6:2425–33.
   PubMed Web of Science ®Google Scholar
• Herbenick D, Reece M, Schick V, et al. Women's use and perceptions of commercial lubricants: Prevalence and characteristics in a nationally representative sample of American adults. J Sex Med 2014;11:642–52.
   PubMed Web of Science ®Google Scholar
• Sutton KS, Boyer SC, Goldfinger C, et al. To lube or not to lube: Experiences and perceptions of lubricant use in women with and without dyspareunia. J Sex Med 2012;9:240–50.
   PubMed Web of Science ®Google Scholar
• O’Connor AM, Tugwell P, Wells GA, et al. A decision aid for women considering hormone therapy after menopause: Decision support framework and evaluation. Patient Educ Couns 1998;33:267–79.
   PubMed Web of Science ®Google Scholar
• Bitzer J, Cupanik V, Fait T, et al. Factors influencing women's selection of combined hormonal contraceptive methods after counselling in 11 countries: Results from a subanalysis of the CHOICE study. Eur J Contracept Reprod Health Care 2013;18:372–80.
   PubMed Web of Science ®Google Scholar
• Deber RB, Kraetschmer N, Urowitz S, Sharpe N. Do people want to be autonomous patients? Preferred roles in treatment decision-making in several patient populations. Health Expect 2007;10:248–58.
   PubMed Web of Science ®Google Scholar
• Gordon JS, McNew R. Developing the online survey. Nurs Clin North Am 2008;43:605–19.
   PubMed Web of Science ®Google Scholar
• Denscombe M. The good research guide: For small-scale social research projects. 2nd ed. Maidenhead, UK: Open University Press 2003: 41–59.
   Google Scholar
• Nathanson AT, Reinert SE. Windsurfing injuries: Results of a paper- and Internet-based survey. Wilderness Environ Med 1999;10:218–25.
   PubMed Web of Science ®Google Scholar
• Meho L. E-mail interviewing in qualitative research: A methodological discussion. J Am Soc Inf Sci Technol 2006;57:1284–95.
   Web of Science ®Google Scholar
• Hardy E, Jimenez AL, de Padua KS, et al. Women's preferences for vaginal antimicrobial contraceptives. III. Choice of a formulation, applicator, and packaging. Contraception 1998;58:245–9.
   PubMed Web of Science ®Google Scholar
• Suckling J, Kennedy R, Lethaby A, Roberts H. Local oestrogen for vaginal atrophy in postmenopausal women. Cochrane Database Syst Rev 2006;4:CD001500.
   Google Scholar
• Mantell JE, Myer L, Carballo-Dieguez A, et al. Microbicide acceptability research: Current approaches and future directions. Soc Sci Med 2005;60:319–30.
   PubMed Web of Science ®Google Scholar
• Guzman S, Snow R, Aitken I. Preferences for contraceptive attributes: Voices of women in Ciudad Juárez, Mexico. Int Fam Plann Perspect 1997;23:52–8.
   Google Scholar
• Dieben TO, Roumen FJ, Apter D. Efficacy, cycle control, and user acceptability of a novel combined contraceptive vaginal ring. Obstet Gynecol 2002;100:585–93.
   PubMed Web of Science ®Google Scholar
• Nurbhai M, Grimshaw J, Watson M, et al. Oral versus intra-vaginal imidazole and triazole anti-fungal treatment of uncomplicated vulvovaginal candidiasis (thrush). Cochrane Database Syst Rev 2007;4:CD002845.
   Google Scholar
• Rosen RK, Morrow KM, Carballo-Dieguez A, et al. Acceptability of tenofovir gel as a vaginal micro- bicide among women in a phase I trial: A mixed- methods study. J Women's Health (Larchmt) 2008;17: 383–92.
   PubMed Web of Science ®Google Scholar
• Rohan LC, Sassi AB. Vaginal drug delivery systems for HIV prevention. AAPS J 2009;11:78–87.
   PubMed Web of Science ®Google Scholar
• Acarturk F. Mucoadhesive vaginal drug delivery systems. Recent Pat Drug Deliv Formul 2009;3:193–205.
   PubMedGoogle Scholar
• Wan GJ, Barnowski CE, Ambegaonkar BM, et al. Treatment satisfaction with a transdermal contraceptive patch or oral contraceptives. Contraception 2007;75:281–4.
   PubMed Web of Science ®Google Scholar
• Mansour D. International survey to assess women's attitudes regarding choice of daily versus nondaily female hormonal contraception. Int J Women's Health 2014;6:367–75.
   PubMedGoogle Scholar
• Bitzer J, Gemzell-Danielsson K, Roumen F, et al. The CHOICE study: Effect of counselling on the selection of combined hormonal contraceptive methods in 11 countries. Eur J Contracept Reprod Health Care 2012;17:65–78.
   PubMed Web of Science ®Google Scholar
• Palmeira-de-Oliveira R, Duarte R, Palmeira-de-Oliveira A, das Neves J, Amaral MH, Breitenfeld L, et al. What do portuguese women prefer regarding vaginal products? Results from a cross-sectional web-based survey. Pharmaceutics. 2014;6:543–56. doi: 10.3390/pharmaceutics6040543
   PubMedGoogle Scholar